UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2014-06, Vol.32 (18), p.1941-1967

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

Quality of life research, 2013-12, Vol.22 (10), p.2787-2799

2013

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Clinical cancer research, 2018-08, Vol.24 (15), p.3602-3610

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Supportive care in cancer, 2016-12, Vol.24 (12), p.5059-5068

2016

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.707-714

2020

Link zum Volltext

Verfügbarkeit prüfen

In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

Cancer control, 2018-01, Vol.25 (1), p.1073274818756608-1073274818756608

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials

Supportive care in cancer, 2017-11, Vol.25 (11), p.3537-3544

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3325-3348

2020

Link zum Volltext

Verfügbarkeit prüfen

Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

Cancer nursing, 2013-09, Vol.36 (5), p.E49

2013

Link zum Volltext

Verfügbarkeit prüfen

The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure

Oncology nursing forum, 2017-09, Vol.44 (5), p.580

2017

Link zum Volltext

Verfügbarkeit prüfen

Chronic Pain and Cognitive Behavioral Therapy: An Integrative Review

Western Journal of Nursing Research, 2016-05, Vol.38 (5), p.596-628

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (13), p.1359

2013

Link zum Volltext

Verfügbarkeit prüfen

Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months

Cancers, 2022-02, Vol.14 (5), p.1212

2022

Link zum Volltext

Verfügbarkeit prüfen

The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums

Cancer nursing, 2010-05, Vol.33 (3), p.173

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Treatments for Chronic Cancer-Related Pain: Does Anything Work?

Journal of clinical oncology, 2019-07, Vol.37 (20), p.1686-1689

Smith, Ellen M Lavoie

2019

Link zum Volltext

Verfügbarkeit prüfen

What about Alice? Peripheral neuropathy from taxane-containing treatment for advanced nonsmall cell lung cancer

Supportive care in cancer, 2014-09, Vol.22 (9), p.2581-2592

2014

Link zum Volltext

Verfügbarkeit prüfen

Adolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption

The Clinical journal of pain, 2023-07, Vol.39 (7), p.326

2023

Link zum Volltext

Verfügbarkeit prüfen

Current methods for the assessment and management of taxane-related neuropathy

Clinical journal of oncology nursing, 2013-02, Vol.17 Suppl, p.22

Smith, Ellen M Lavoie

2013

Link zum Volltext

Verfügbarkeit prüfen

Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

Journal of the peripheral nervous system, 2015-03, Vol.20 (1), p.37-46

2015

Link zum Volltext

Verfügbarkeit prüfen

Vincristine-induced peripheral neuropathy in pediatric cancer patients

American journal of cancer research, 2016-01, Vol.6 (11), p.2416-2430

2016

Link zum Volltext

Verfügbarkeit prüfen

The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy

Oncology nursing forum, 2008-01, Vol.35 (1), p.96

2008

Link zum Volltext

Verfügbarkeit prüfen

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data

Cancer nursing, 2019-05, Vol.42 (3), p.179

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Pre-Diagnosis Physical Activity and Its Correlates between Lung and Other Cancer Patients: Accelerometer Data from the UK Biobank Prospective Cohort

International journal of environmental research and public health, 2023-01, Vol.20 (2), p.1001

2023

Link zum Volltext

Verfügbarkeit prüfen

Unfolding parental knowledge, attitudes, and beliefs toward palliative care for children with cancer

Pediatric blood & cancer, 2023-09, Vol.70 (9), p.e30484-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Supportive care in cancer, 2019-07, Vol.27 (7), p.2599-2608

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(83)
Buchkapitel
(2)

Sprache

Englisch
(85)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(66)
Humans
(59)
Oncology
(43)
Female
(38)
Nursing
(37)
Male
(29)
Peripheral Nervous System Diseases - Chemically Induced
(28)
Adult
(27)
Aged
(25)
Cancer
(25)
Middle Aged
(24)
Antineoplastic Agents - Adverse Effects
(23)
Chemotherapy
(23)
Chemotherapy-Induced Peripheral Neuropathy
(19)
Peripheral Neuropathy
(19)
Pain
(15)
Patients
(14)
Quality Of Life
(14)
Care And Treatment
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure

Chronic Pain and Cognitive Behavioral Therapy: An Integrative Review

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months

The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums

Pharmacologic Treatments for Chronic Cancer-Related Pain: Does Anything Work?

What about Alice? Peripheral neuropathy from taxane-containing treatment for advanced nonsmall cell lung cancer

Adolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption

Current methods for the assessment and management of taxane-related neuropathy

Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

Vincristine-induced peripheral neuropathy in pediatric cancer patients

The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy

Comparison of Pre-Diagnosis Physical Activity and Its Correlates between Lung and Other Cancer Patients: Accelerometer Data from the UK Biobank Prospective Cohort

Unfolding parental knowledge, attitudes, and beliefs toward palliative care for children with cancer

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Suchergebnisse filtern